In the latest trading session,, 1.12 million Roivant Sciences Ltd (NASDAQ:ROIV) shares changed hands as the company’s beta touched 1.22. With the company’s most recent per share price at $11.23 changing hands around $0.04 or 0.40% at last look, the market valuation stands at $8.02B. ROIV’s current price is a discount, trading about -16.3% off its 52-week high of $13.06. The share price had its 52-week low at $8.73, which suggests the last value was 22.26% up since then. When we look at Roivant Sciences Ltd’s average trading volume, we note the 10-day average is 6.08 million shares, with the 3-month average coming to 6.27 million.
Analysts gave the Roivant Sciences Ltd (ROIV) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.20. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ROIV as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight.
Roivant Sciences Ltd (NASDAQ:ROIV) trade information
Instantly ROIV is in green as seen in intraday trades today. With action 7.82%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -5.03%, with the 5-day performance at 7.82% in the green. However, in the 30-day time frame, Roivant Sciences Ltd (NASDAQ:ROIV) is 8.24% up. Looking at the short shares, we see there were 51.23 million shares sold at short interest cover period of 5.86 days.
The consensus price target for the stock as assigned by Wall Street analysts is 17, meaning bulls need an upside of 33.94% from its recent market value. According to analyst projections, ROIV’s forecast low is 12.5 with 20 as the target high. To hit the forecast high, the stock’s price needs a -78.09% plunge from its current level, while the stock would need to soar -11.31% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0.08%. The 2025 estimates are for Roivant Sciences Ltd earnings to decrease by -109.96%.
ROIV Dividends
Roivant Sciences Ltd is expected to release its next quarterly earnings report on 2025-Feb-09.
Roivant Sciences Ltd (NASDAQ:ROIV)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 27.68% of Roivant Sciences Ltd shares while 80.04% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 110.67%. There are 80.04% institutions holding the Roivant Sciences Ltd stock share, with SB INVESTMENT ADVISERS (UK) LTD the top institutional holder. As of 2024-06-30, the company held 9.6983% of the shares, roughly 71.36 million ROIV shares worth $754.29 million.
VIKING GLOBAL INVESTORS LP holds the second largest percentage of outstanding shares, with 9.3985% or 69.16 million shares worth $730.98 million as of 2024-06-30.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 16.64 shares estimated at $186.71 million under it, the former controlled 2.33% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.06% of the shares, roughly 14.71 shares worth around $165.02 million.
